Many people with diabetes have the earliest stage of diabetic retinopathy, called mild nonproliferative diabetic retinopathy (NPDR), without even knowing it, according to the American Academy of ...

Two large NIH-funded clinical studies have shown promising results that laser photocoagulation therapy prevents vision loss in patients with diabetic retinopathy. Results of the Diabetic Retinopathy ...

Eye injections are the only medication currently available to treat diabetes-related retinopathy. Modern eye injections are not painful and don’t cause many side effects. Diabetic retinopathy affects ...

Moore’s widower, S. Robert Levine, MD, launched the nonprofit in his famous wife’s memory to advance research and accelerate ...

Retinopathy refers to conditions or damage affecting the retina. Without treatment, it can cause blindness. Hypertensive retinopathy results from high blood pressure, while diabetic retinopathy is a ...

This story is part of a series on the current progression in Regenerative Medicine. This piece is part of a series dedicated to the eye and improvements in restoring vision. This piece also marks part ...

Treating people in the early stages of diabetes-related eye disease may help slow the progression of the condition, but a new study also suggests that it can’t help prevent vision loss in the future.

Proliferative diabetic retinopathy (PDR) is the advanced stage of diabetic retinopathy. It involves the development of abnormal retinal blood vessels. The vessels may leak blood and fluid into the ...

Patients with diabetes are at risk of developing retinopathy, a common complication that can cause blindness. Researchers say 8 million people do not know they have diabetes. The longer a person has ...

INDICATIONS EYLEA HD ® (aflibercept) Injection 8 mg is a prescription medicine approved for the treatment of patients with Wet Age-Related Macular Degeneration (AMD), Diabetic Macular Edema (DME), and ...

Diabetic retinopathy involves damage to the eye’s retina due to high blood sugar levels in the body. It is a common complication of diabetes, affecting millions of people with both type 1 and type 2 ...

Please provide your email address to receive an email when new articles are posted on . Ocuphire Pharma reported oral APX3330 for the treatment of diabetic retinopathy failed to meet the primary ...